Alpha Tau Medical Ltd. (DRTS)
Nasdaq: DRTS · Surgical & Medical Instruments & Apparatus · Jerusalem, IL · filing with the SEC since 2021
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
| Report filed | Mar 9, 2026 | Mar 12, 2025 | Mar 7, 2024 | Mar 9, 2023 | Mar 28, 2022 | · | · |
| Research and development | 32,065 | 27,020 | 26,424 | 20,890 | 11,447 | 7,544 | 6,636 |
| General and administrative | 8,363 | 6,673 | 7,332 | 10,272 | 1,861 | 1,412 | 977 |
| Operating income | -42,288 | -36,042 | -35,680 | -32,136 | -13,790r | -9,244r | 8,010 |
| Interest expense | 347 | 303 | 75 | · | · | · | · |
| Total non-operating income (expense) | -218 | 4,298 | 6,539 | -1,606 | -13,474 | · | · |
| Income before income taxes | -42,506 | -31,744 | -29,141 | -33,742 | -27,264r | -8,724r | 8,318 |
| Income tax expense | 121 | 6 | 16 | 20 | 7r | 158r | -146 |
| Income from continuing operations | · | · | · | -33,762 | -27,271 | -8,882 | -8,367 |
| Net income including non-controlling interests | · | · | · | · | 27,271 | 8,882 | 8,464 |
| Net income to non-controlling interests | · | · | · | · | · | · | -97 |
| Net income | -42,627 | -31,750 | -29,157 | -33,762 | -27,271 | -8,882 | -8,367 |
| Earnings per share, basic | -0.53 | -0.45 | -0.42 | -0.53 | -0.67 | -0.22 | -0.25 |
| Earnings per share, diluted | -0.53 | -0.45 | -0.42 | -0.53 | -0.67 | -0.22 | -0.25 |
| Weighted average shares, basic | 80,581,440 | 69,927,566 | 69,377,922 | 63,534,875 | 40,534,697 | 40,274,935 | 33,815,448 |
| Weighted average shares, diluted | 80,581,440 | 69,927,566 | 69,377,922 | 63,534,875 | 40,534,697 | 40,274,935 | 33,815,448 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperatingTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitIncome from continuing operations profit from the businesses it keeps
us-gaap:IncomeLossFromContinuingOperationsNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding